These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12116607)

  • 41. [Antiestrogens--benefits of estrogens without their disadvantages?].
    Välimäki MJ; Tiitinen A
    Duodecim; 1998; 114(19):1885, 1887-8. PubMed ID: 11717742
    [No Abstract]   [Full Text] [Related]  

  • 42. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
    Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
    Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?
    Holtorf K
    Postgrad Med; 2009 Jan; 121(1):73-85. PubMed ID: 19179815
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in women's use of hormones after the Women's Health Initiative estrogen and progestin trial by race, education, and income.
    Wei F; Miglioretti DL; Connelly MT; Andrade SE; Newton KM; Hartsfield CL; Chan KA; Buist DS
    J Natl Cancer Inst Monogr; 2005; (35):106-12. PubMed ID: 16287895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention of hormone-related cancers: breast cancer.
    Dunn BK; Wickerham DL; Ford LG
    J Clin Oncol; 2005 Jan; 23(2):357-67. PubMed ID: 15637398
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HRT, HERS, NIH, WHI: alphabet soup?
    Legato MJ
    J Gend Specif Med; 2002; 5(6):10-3. PubMed ID: 12503220
    [No Abstract]   [Full Text] [Related]  

  • 48. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Time for new long-term trials of postmenopausal hormone therapies!
    MacLennan A; Sturdee DW
    Climacteric; 2003 Dec; 6(4):265-7. PubMed ID: 15006246
    [No Abstract]   [Full Text] [Related]  

  • 50. The medical management of menopause: to treat or not to treat?
    Barlow DH
    Ann N Y Acad Sci; 2008 Apr; 1127():134-9. PubMed ID: 18443341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Hormone replacement therapy for internal risk patients].
    Mueck AO
    Gynakol Geburtshilfliche Rundsch; 2006; 46(4):174-90. PubMed ID: 17068402
    [TBL] [Abstract][Full Text] [Related]  

  • 52. From the challenge to the reassessment of the Women's Health Initiative: a personal initiative for women's health.
    Gambacciani M; Genazzani AR
    Gynecol Endocrinol; 2006 Mar; 22(3):115-6. PubMed ID: 16835071
    [No Abstract]   [Full Text] [Related]  

  • 53. Can estrogen or selective estrogen-receptor modulators preserve cognitive function in elderly women?
    Mayeux R
    N Engl J Med; 2001 Apr; 344(16):1242-4. PubMed ID: 11309641
    [No Abstract]   [Full Text] [Related]  

  • 54. Postmenopausal hormone therapy and cardiovascular risk.
    VandeKieft G
    J Fam Pract; 1996 Nov; 43(5):437-8. PubMed ID: 8917138
    [No Abstract]   [Full Text] [Related]  

  • 55. Estrogen therapy and cardiovascular risk in women.
    Bass KM; Bush TL
    J La State Med Soc; 1991 May; 143(5):33-9. PubMed ID: 1861096
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coronary heart disease in women.
    Anderson PW; Moscarelli E
    N Engl J Med; 2000 Dec; 343(25):1892; author reply 1892-4. PubMed ID: 11117987
    [No Abstract]   [Full Text] [Related]  

  • 57. Estrogen replacement therapy (ERT) and hormone replacement therapy (HRT) in the prevention of cardiovascular diseases.
    Nikolov R; Golbs S; Schneider HP
    Zentralbl Gynakol; 1999; 121(2):101-4. PubMed ID: 10096179
    [No Abstract]   [Full Text] [Related]  

  • 58. Controversial aspects of hormone replacement therapy upon cardiovascular mortality and morbidity of women in menopause.
    Rosano GM; Mercuro G
    G Ital Cardiol; 1999 Sep; 29(9):999-1003. PubMed ID: 10514956
    [No Abstract]   [Full Text] [Related]  

  • 59. Another chapter in the heart and estrogen story.
    Harv Womens Health Watch; 2001 Apr; 8(8):1-2. PubMed ID: 11340038
    [No Abstract]   [Full Text] [Related]  

  • 60. Hormone replacement therapy: current controversies.
    Davison S; Davis SR
    Clin Endocrinol (Oxf); 2003 Mar; 58(3):249-61. PubMed ID: 12608928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.